ClinicalTrials.Veeva

Menu

Open Uncontrolled Validation Study for the German Version of the Actinic Keratosis Quality of Life Questionnaire (AKQoL) (AKQOLVS)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Actinic Keratosis

Treatments

Other: cognitive interviewing

Study type

Interventional

Funder types

Other

Identifiers

NCT02325661
KEK-ZH-Nr. 2014-0252

Details and patient eligibility

About

The objective of this study is to translate the "AKQoL"-questionnaire which measures the quality of life of patients with actinic keratosis into German and to validate it for the Swiss population.

By using the technique of cognitive interviewing the investigators are focussing on the patients' understanding of the questions. The first session of cognitive interviews will show, where there is need for improvement in terms of misinterpreted phrases or vaguely worded questions. The goal is to rephrase the questions according to the feedback of the patients. The revised version will then be presented to a new population.

Full description

Actinic keratosis is a UV-induced skin disease, which presents as a reddish, squamous and sometimes itchy lesion. Actinic keratosis seems to have a negative impact on patients' quality of life. Esmann et al. elaborated on patients with actinic keratosis from Zealand, Denmark a questionnaire which measures the quality of life.

The objective of this study is to translate this questionnaire into German and to validate it for the Swiss population. This questionnaire might become part of a planned national register for data collection of patients with AK.

The investigators will assess the content validity of the questionnaire by using the technique of cognitive interviewing. The investigators are going to talk 34 patients with AK from the department of Dermatology, University Hospital Zurich through the translated version. Thereby, the investigators are focusing on the patients' understanding of the questions.

The first session of cognitive interviews will show, where there is need for improvement in terms of misinterpreted phrases or vaguely worded questions. The goal is to rephrase the questions in the sense that they become more clear and are understood by different interviewee in the same way. The revised version will then be presented to a new population. The performance of cognitive interview sessions and revisions will continue until the survey will be approved by at least 80% of the respondents.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with actinic keratosis of the department of Dermatology, University Hospital Zurich
  • Male and Female subjects > 18 years of age
  • Good understanding of written and spoken German
  • Sufficient physical and mental capacity to comprehend the questions
  • Written informed consent by the participant

Exclusion criteria

  • Lack of informed consent

Trial design

34 participants in 1 patient group

cognitive interviewing
Other group
Description:
individual cognitive interviewing, 30 minutes per patient
Treatment:
Other: cognitive interviewing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems